Video: MS&L on FDA Social Media Hearing - Day 1

Article

Related Videos
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
Etienne Sibille, PhD: Innovations in Cognitive Pathology
Katharine Phillips, MD: Various Treatments for Obsessive-Compulsive Disorders
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
Katharine Phillips, MD: Differences Between OCD, Body Dysmorphic Disorder
Brian Barnett, MD: Psychedelics Fitting into the SUDs Treatment Paradigm
Related Content
Martin Maron, MD | Credit: HCM Academy

Aficamten Showcases oHCM Benefit in Phase 3 SEQUOIA-HCM Trial

May 13th 2024
Article
2024 State of the Air: Record Highs in US Particle Pollution, with Dr. John Balmes

2024 State of the Air: Record Highs in US Particle Pollution, with John Balmes, MD

April 24th 2024
Podcast
Rahul Aggarwal, MD | Credit: LinkedIn

Nearly 90% of US Adults Meet Cardiovascular-Kidney-Metabolic Syndrome Criteria

May 13th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
Zane Elfessi, PharmD | Credit: LinkedIn

A1AT Phenotyping Lags Behind, Contributes to Underrecognition of AATD

May 10th 2024
Article
Steve Ommen, MD | Credit: Mayo Clinic

New Cardiomyopathy Guidelines Endorse Cardiac Myosin Inhibitors, Expanded Role for Exercise

May 9th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.